This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Seung Kee Moon: Innovator in Cancer Treatment
Introduction
Seung Kee Moon is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.
Latest Patents
One of his notable patents is the "Anti-c-Met antibody and use thereof." This invention relates to a unique antibody or an antigen binding fragment that specifically binds to the human hepatocyte growth factor receptor (c-Met). The composition developed from this antibody is aimed at preventing or treating cancer. It demonstrates excellent cancer cell proliferation inhibitory activity and remarkable anticancer effects, even in minimal amounts, making it a promising option for effective cancer treatment.
Career Highlights
Seung Kee Moon is associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to advance his research in the pharmaceutical field. His work has garnered attention for its potential impact on cancer therapies.
Collaborations
He has collaborated with notable colleagues, including Ki Young An and Eun Su Choi, to further enhance the development of innovative treatments.
Conclusion
Seung Kee Moon's contributions to cancer treatment through his patented inventions highlight his role as a key innovator in the pharmaceutical industry. His work continues to inspire advancements in medical research and cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile